Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-26 @ 3:13 AM
Study NCT ID:
NCT01100320
Status:
COMPLETED
Last Update Posted:
2010-05-11
First Post:
2010-04-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
Sponsor:
Purdue Pharma LP
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2007-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-07
First Submit QC Date:
None
Study First Post Date:
2010-04-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-04-13
Results First Submit QC Date:
None
Results First Post Date:
2010-05-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-05-06
Last Update Post Date:
2010-05-11
Last Update Post Date Type:
ESTIMATED